Drug watchdog backs new breast cancer drugs (Reuters, 22 Nov 2006)
New drug could prevent prostate gland swelling (MSNBC, 6 Nov 2006)

Synthetic hormone may boost heart risks in kidney patients (LATimes, via NEJM, 16 Nov 2006)

23 Nov 2006

The increasingly common practice of using a synthetic form of the hormone EPO to maintain normal red blood cell levels in chronic kidney disease patients may increase cardiovascular risks, according to a study published today in the New England Journal of Medicine.

Full article

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read